Why Early Referral for Fertility Preservation is Critical in Oncology скачать в хорошем качестве

Why Early Referral for Fertility Preservation is Critical in Oncology

Watch the full interview on Oncology Data Advisor: https://oncdata.com/oncofertility-mea... Fertility preservation is an essential component of comprehensive cancer care for patients of reproductive age. In this discussion, Meaghan Delaney, MD, Co-Director of the Oncofertility Program at Boston IVF, shares insights on how oncology clinicians can help patients navigate the impact of cancer therapy on future family building. Dr. Delaney explains how various treatments, particularly alkylating agents, affect reproductive function and highlights the importance of rapid, coordinated care. She reviews standard preservation options, including oocyte, embryo, and sperm cryopreservation, as well as emerging techniques like ovarian tissue cryopreservation for prepubertal patients. The conversation emphasizes why early referral is vital (ideally allowing for a two-week window before treatment starts) and explores the emotional and financial support systems available to patients. Dr. Delaney also provides practical advice for clinicians on starting these sensitive conversations and utilizing resources like the Oncofertility Consortium and SaveMyFertility. #Oncofertility #FertilityPreservation #CancerCare #Oncology #ReproductiveHealth #BreastCancer #LCSM #Survivorship #PatientSupport #FamilyBuilding #MedicalEducation #news #cancer #cancercare